Skip to main content

August 2016 Vol 9, Special Issue: Payers' Perspectives in Oncology

Prostate Cancer
Is the Glass Half Empty or Half Full? First Study Compares Robotic-Assisted Surgery and Open Radical Prostatectomy
Alice Goodman
Read More
Lung Cancer, Oncology
Nivolumab plus Ipilimumab Combination Promotes Durable Responses in Advanced Lung Cancer
Wayne Kuznar
Read More
Prostate Cancer
Shorter Hypofractionated Therapy New Standard for Prostate Cancer
Phoebe Starr
Read More
Lung Cancer, Oncology
Alectinib Potential First-Line Treatment for NSCLC Associated with ALK Mutation
Wayne Kuznar
Read More
Conference Correspondent
Read More
FDA Approvals
Biosimilar to Trastuzumab Shows Equivalent Efficacy and Safety
Phoebe Starr
Read More
FDA Approvals
Novel Vaccine Induces Immunologic Responses in Patients with Acute Myeloid Leukemia
Wayne Kuznar
Read More
FDA Approvals
New Standard in Elderly Patients with Glioblastoma Based on Phase 3 Evidence
Phoebe Starr
Read More
FDA Approvals
Novel Chimeric Monoclonal Antibody Improves Survival in Advanced Gastric Cancers
Wayne Kuznar
Read More
FDA Approvals
Adding the BCL-2 Inhibitor Venetoclax to Treatment Regimen Promising in Relapsed or Refractory Multiple Myeloma
Wayne Kuznar
Read More
Page 2 of 4
Results 11 - 20 of 32